PV pharm branch, vendor, cage 0U9U0

Ended Awarded Last action

Contract number
SPE2D826F0CSQ
Awardee
Awarding agency
Obligated
$32,120

Award facts

Contract value 100% obligated
$32,119.80 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325411 Medicinal and Botanical Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

This delivery order, awarded on December 29, 2025, represents a $32,119.80 firm fixed-price contract issued by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) for pharmaceutical and medical supply deliveries. The contract, which is not set-aside and competitively awarded, carries an ultimate completion date of December 30, 2025, with performance to occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply diverse pharmaceutical products and medical supplies to military healthcare programs worldwide.

AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, leverages its extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support Defense Health Agency requirements and other federal healthcare systems. The company's demonstrated capability to fulfill federal procurement needs through open competition, combined with its significant scale and therapeutic product range spanning diabetes medications, neurological treatments, pain management pharmaceuticals, and other critical medical supplies, positions it as a key supplier for military and veteran healthcare logistics. The DLA's planned establishment of Pharmaceutical Prime Vendor Global Program Generation V contracts, which envisions multiple regional awards across several contractors, underscores the strategic importance of vendors like AmerisourceBergen in maintaining robust pharmaceutical supply chains for the Department of Defense.

Quick answers

Who was awarded contract SPE2D826F0CSQ?

SPE2D826F0CSQ was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on December 29, 2025.

How much is contract SPE2D826F0CSQ worth?

The government has obligated $32,120 on SPE2D826F0CSQ.

Is contract SPE2D826F0CSQ an order under another contract?

Yes. SPE2D826F0CSQ is a delivery order under SPE2DX22D0129, an indefinite delivery contract.

Was contract SPE2D826F0CSQ competed?

The extent of competition for SPE2D826F0CSQ was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award